An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

Clinical trial NCT05226468 · UNKNOWN

Trial details

NCT number: NCT05226468
Sponsor: New Epsilon Innovation Limited
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Relapsed AML Refractory AML

Start date: 2022-04-25
Primary completion: 2024-01-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.